Bayesian Capital Management, LP Ab Cellera Biologics Inc. Transaction History

Bayesian Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$5.66 - $7.59 $97,352 - $130,548	17,200 Added 91.05%	36,090 $233,000
Q1 2023 May 15, 2023	SELL	$7.31 - $11.18 $120,615 - $184,470	-16,500 Reduced 46.62%	18,890 $142,000
Q4 2022 Feb 14, 2023	BUY	$9.48 - $14.52 $4,740 - $7,260	500 Added 1.43%	35,390 $358,000
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $74,520 - $110,808	8,100 Added 30.24%	34,890 $345,000
Q2 2022 Aug 15, 2022	SELL	$5.72 - $10.65 $5,205 - $9,691	-910 Reduced 3.29%	26,790 $285,000
Q1 2022 May 16, 2022	BUY	$7.46 - $14.14 $206,642 - $391,678	27,700 New	27,700 $270,000
Q3 2021 Nov 15, 2021	SELL	$14.85 - $21.34 $340,065 - $488,686	-22,900 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$20.19 - $34.17 $462,351 - $782,493	22,900 New	22,900 $504,000

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $807M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.